Detalhe da pesquisa
1.
Safety and efficacy of tenalisib in combination with romidepsin in patients with relapsed/refractory T-cell lymphoma: results from a phase I/II open-label multicenter study.
Haematologica
; 109(1): 209-219, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37439343
2.
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(3): 285-308, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35276674
3.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
4.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021.
J Natl Compr Canc Netw
; 18(11): 1460-1467, 2020 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33152703
5.
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
J Natl Compr Canc Netw
; 18(5): 522-536, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32380458
6.
PD-1 blockade for relapsed lymphoma post-allogeneic hematopoietic cell transplant: high response rate but frequent GVHD.
Blood
; 130(2): 221-228, 2017 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28468799
7.
Peripheral T-Cell Lymphoma, not Otherwise Specified (PTCL-NOS).
Cancer Treat Res
; 176: 83-98, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30596214
8.
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.
J Natl Compr Canc Netw
; 16(2): 123-135, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439173
9.
Frequency and clinical correlates of elevated plasma Epstein-Barr virus DNA at diagnosis in peripheral T-cell lymphomas.
Int J Cancer
; 140(8): 1899-1906, 2017 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27943278
10.
PD-1 Blockade in Mediastinal Gray-Zone Lymphoma.
N Engl J Med
; 377(1): 89-91, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679093
11.
The CNS Relapse in T-Cell Lymphoma Index Predicts CNS Relapse in Patients with T- and NK-Cell Lymphomas.
Blood Adv
; 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38739715
12.
Rational Targets of Therapy in Extranodal NK/T-Cell Lymphoma.
Cancers (Basel)
; 15(5)2023 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900160
13.
CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model.
FEBS Open Bio
; 13(7): 1309-1319, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37157185
14.
Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions.
Blood Adv
; 7(16): 4528-4538, 2023 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37026796
15.
HIV-associated Burkitt lymphoma: outcomes from a US-UK collaborative analysis.
Blood Adv
; 5(14): 2852-2862, 2021 07 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283175
16.
Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation.
Bone Marrow Transplant
; 55(4): 780-786, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31664185
17.
Phase I/Ib Study of Tenalisib (RP6530), a Dual PI3K δ/γ Inhibitor in Patients with Relapsed/Refractory T-Cell Lymphoma.
Cancers (Basel)
; 12(8)2020 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32824175
18.
Extreme Peripheral Blood Plasmacytosis Mimicking Plasma Cell Leukemia as a Presenting Feature of Angioimmunoblastic T-Cell Lymphoma (AITL).
Front Oncol
; 9: 509, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31263679
19.
Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone.
Clin Cancer Res
; 24(14): 3273-3281, 2018 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29632007
20.
Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.
Blood Adv
; 2(8): 933-940, 2018 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29685953